Contraception: Your Questions Answered (Paperback, 7th edition)

,
This seventh edition has been completely revised and updated, incorporating relevant WHO and national guidance documents: therefore imparting best evidence-based practice for all methods. Combined oral contraceptives (COCs) Based on the long-established evidence that 7 days of routinely not-taking pills in each cycle is too long for maintained ovarian suppression - and this necessarily leads to too little margin for errors in pill-taking - the authors recommend that providers switch to a new norm for all users of either: Tricycling, the 84/4 regimen, or totally continuous use (365/365), OR, for women who remain keen to see monthly pill-bleeds (which are completely unnecessary for health), one of the regimens (24/4 or 21/4) that shorten the contraception-non-taking time to 4 days New methods, and their importance or otherwise: Intrauterine system: Jaydess (R) Subcutaneous, self-injectable alternative to Depo-Provera: Sayana (R) Press 24/4 combined hormonal contraceptives: Zoely (R), Eloine (R) Diaphragm: Caya (R) Updates Quick starting and bridging (the Proving not Pregnant Protocol) Emergency contraception (EC), how advice differs for ulipristal acetate EC Drug metabolism (implications with norethisterone) and interactions (eg affecting lamotrigine) Question and answer format Important information boxes Unwanted side effects boxes Frequent patient questions at the end of relevant chapters Management advice Follow-up advice Comes with free e-book on ExpertConsult for the first time This seventh edition has been completely revised and updated, incorporating relevant WHO and national guidance documents: therefore imparting best evidence-based practice for all methods. Combined oral contraceptives (COCs) Based on the long-established evidence that 7 days of routinely not-taking pills in each cycle is too long for maintained ovarian suppression - and this necessarily leads to too little margin for errors in pill-taking - the authors recommend that providers switch to a new norm for all users of either: Tricycling, the 84/4 regimen, or totally continuous use (365/365), OR, for women who remain keen to see monthly pill-bleeds (which are completely unnecessary for health), one of the regimens (24/4 or 21/4) that shorten the contraception-non-taking time to 4 days New methods, and their importance or otherwise: Intrauterine system: Jaydess (R) Subcutaneous, self-injectable alternative to Depo-Provera: Sayana (R) Press 24/4 combined hormonal contraceptives: Zoely (R), Eloine (R) Diaphragm: Caya (R) Updates Quick starting and bridging (the Proving not Pregnant Protocol) Emergency contraception (EC), how advice differs for ulipristal acetate EC Drug metabolism (implications with norethisterone) and interactions (eg affecting lamotrigine) Intermittent quizzes for CPD portfolio purposes Now on ExpertConsult

R1,120
List Price R1,188
Save R68 6%

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles11200
Mobicred@R105pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 12 - 17 working days


Toggle WishListAdd to wish list
Review this Item

Product Description

This seventh edition has been completely revised and updated, incorporating relevant WHO and national guidance documents: therefore imparting best evidence-based practice for all methods. Combined oral contraceptives (COCs) Based on the long-established evidence that 7 days of routinely not-taking pills in each cycle is too long for maintained ovarian suppression - and this necessarily leads to too little margin for errors in pill-taking - the authors recommend that providers switch to a new norm for all users of either: Tricycling, the 84/4 regimen, or totally continuous use (365/365), OR, for women who remain keen to see monthly pill-bleeds (which are completely unnecessary for health), one of the regimens (24/4 or 21/4) that shorten the contraception-non-taking time to 4 days New methods, and their importance or otherwise: Intrauterine system: Jaydess (R) Subcutaneous, self-injectable alternative to Depo-Provera: Sayana (R) Press 24/4 combined hormonal contraceptives: Zoely (R), Eloine (R) Diaphragm: Caya (R) Updates Quick starting and bridging (the Proving not Pregnant Protocol) Emergency contraception (EC), how advice differs for ulipristal acetate EC Drug metabolism (implications with norethisterone) and interactions (eg affecting lamotrigine) Question and answer format Important information boxes Unwanted side effects boxes Frequent patient questions at the end of relevant chapters Management advice Follow-up advice Comes with free e-book on ExpertConsult for the first time This seventh edition has been completely revised and updated, incorporating relevant WHO and national guidance documents: therefore imparting best evidence-based practice for all methods. Combined oral contraceptives (COCs) Based on the long-established evidence that 7 days of routinely not-taking pills in each cycle is too long for maintained ovarian suppression - and this necessarily leads to too little margin for errors in pill-taking - the authors recommend that providers switch to a new norm for all users of either: Tricycling, the 84/4 regimen, or totally continuous use (365/365), OR, for women who remain keen to see monthly pill-bleeds (which are completely unnecessary for health), one of the regimens (24/4 or 21/4) that shorten the contraception-non-taking time to 4 days New methods, and their importance or otherwise: Intrauterine system: Jaydess (R) Subcutaneous, self-injectable alternative to Depo-Provera: Sayana (R) Press 24/4 combined hormonal contraceptives: Zoely (R), Eloine (R) Diaphragm: Caya (R) Updates Quick starting and bridging (the Proving not Pregnant Protocol) Emergency contraception (EC), how advice differs for ulipristal acetate EC Drug metabolism (implications with norethisterone) and interactions (eg affecting lamotrigine) Intermittent quizzes for CPD portfolio purposes Now on ExpertConsult

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Elsevier health sciences

Country of origin

United Kingdom

Series

Your Questions Answered

Release date

August 2017

Availability

Expected to ship within 12 - 17 working days

First published

2018

Authors

,

Dimensions

216 x 133 x 19mm (L x W x T)

Format

Paperback

Pages

424

Edition

7th edition

ISBN-13

978-0-7020-7000-6

Barcode

9780702070006

Categories

LSN

0-7020-7000-9



Trending On Loot